摘要
一氧化氮(NO),作为一个重要的信号分子,参与诸如心血管稳态、神经传导,免疫调节,和肿瘤的生长等生理过程。因此,不同种类的NO药物包括diazeniumdiolates,S-亚硝基硫醇,亚硝酰,硝基苯等等已经被开发应用。然而,这些低分子量的NO供体已因突发释放,低载荷和无靶点传递问题限制了其临床应用。基于生物材料的载体的NO传递提供了一个有益的策略,实现了NO对靶组织或器官的控制和持续传递。确切来说,通过物理、化学手段或超分子技术,NO供体药物前体已贴装不同的材料来制备纳米颗粒,凝胶,和涂层的平台。这些NO释放的生物材料广泛应用于治疗缺血性疾病、癌症和心血管疾病和伤口愈合的治疗。首先,没有释放的生物材料表面涂层可以模拟血管内皮细胞的生理功能,从而促进血管生成及改善心血管植入物的通畅。其次,因为NO也介导了许多发生在皮肤损伤后的重要过程,无释放的生物材料可以作为理想的伤口敷料,以加速组织再生。最后,生物材料使高剂量的NO传递到肿瘤,从而产生有效的抗肿瘤作用。在这篇综述中,我们将总结不同的NO释放生物材料的进展,并强调他们的生物医学应用,希望能够激发有关生物材料为基础的NO传递系统新的观点。
关键词: 一氧化氮,生物材料,控制交货,生物医学应用,心血管疾病,癌症。
Current Medicinal Chemistry
Title:Nitric Oxide-Releasing Biomaterials for Biomedical Applications
Volume: 23 Issue: 24
Author(s): Xin Zhou, Jimin Zhang, Guowei Feng, Jie Shen, Deling Kong, Qiang Zhao
Affiliation:
关键词: 一氧化氮,生物材料,控制交货,生物医学应用,心血管疾病,癌症。
摘要: Nitric oxide (NO), as an essential signaling molecule, participates in various physiological processes such as cardiovascular homeostasis, neuronal transmission, immunomodulation, and tumor growth. The multiple role of NO in physiology and pathophysiology has triggered a massive interest in the strategies of delivering exogenous NO for biomedical applications. Hence, different kinds of NO prodrugs have been developed up to date, including diazeniumdiolates, S-nitrosothiol, metal-nitrosyl, nitrobenzene, and so on. However, the clinical application of these low molecular weight NO donors has been restricted due to the problems of burst release, low payloads, and untargeted delivery. The delivery of NO by biomaterialbased carrier offers a beneficial strategy to realize the controlled and sustained delivery of NO to the targeted tissues or organs. In detail, NO-donor prodrugs have been attached and loaded to diverse biomaterials to fabricate nanoparticles, hydrogels, and coating platforms by means of physical, chemical, or supramolecular techniques. These NO-releasing biomaterials hold promise for a number of biomedical applications ranging from therapy of the ischemic disease and several types of cancer to cardiovascular devices and wound dressing. First, surface coating with NO-releasing biomaterials could mimic the physiological function of vascular endothelium, therefore promoting vascularization and improving the patency of cardiovascular implants. Next, because NO also mediates many important processes that take place after cutaneous injury, NO-releasing biomaterials could serve as ideal wound dressing to accelerate tissue regeneration. Finally, biomaterials enable localized delivery of high dose of NO to tumors in a sustained manner, thus generating potent tumoricidal effect. In this review, we will summarize the progress of different NO-releasing biomaterials, and highlight their biomedical applications with a hope to inspire new perspectives in the area of biomaterial-based NO-delivery systems.
Export Options
About this article
Cite this article as:
Xin Zhou, Jimin Zhang, Guowei Feng, Jie Shen, Deling Kong, Qiang Zhao , Nitric Oxide-Releasing Biomaterials for Biomedical Applications, Current Medicinal Chemistry 2016; 23 (24) . https://dx.doi.org/10.2174/0929867323666160729104647
DOI https://dx.doi.org/10.2174/0929867323666160729104647 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Moving Average Analysis for Development of Multi-Target (Q)SAR Models
Mini-Reviews in Medicinal Chemistry Wave Intensity Analysis in the Human Coronary Circulation in Health and Disease
Current Cardiology Reviews Adipokines and Myokines: A Pivotal Role in Metabolic and Cardiovascular Disorders
Current Medicinal Chemistry Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis
Current Pharmaceutical Design Atrial Fibrillation Recurrence: The Roles of Hypertension, Duration of Atrial Fibrillation Disease, and Prolonged Signal-Averaged P Wave Duration
Current Cardiology Reviews Mitochondria-Targeted Drugs
Current Molecular Pharmacology EDITORIAL [Hot Topic-II: PPAR Ligands and Cardiovascular Disorders: Friend or Foe (Guest Editors: Pitchai Balakumar and Gowraganahalli Jagadeesh)]
Current Molecular Pharmacology Thioridazine: The Good and the Bad
Recent Patents on Anti-Infective Drug Discovery Non-cholesterol Sterols in the Diagnosis and Treatment of Dyslipidemias: A Review
Current Medicinal Chemistry Global Account of Barriers and Facilitators of Physical Activity Among Patients with Diabetes Mellitus: A Narrative Review of the Literature
Current Diabetes Reviews Drug Eluting Stents: Friend or Foe? A Review of Cellular Mechanisms Behind the Effects of Paclitaxel and Sirolimus Eluting Stents
Current Drug Metabolism Current Concepts in the Management of Diabetic Polyneuropathy
Current Diabetes Reviews Medicinal Plants and Cancer Chemoprevention
Current Drug Metabolism Recent Advances in the Synthesis of 1,3-Azoles
Current Topics in Medicinal Chemistry Critical Roles of Insulin-Induced Senescence in Diabetic Vasculopathy
Vascular Disease Prevention (Discontinued) Diet Bioactive Compounds: Implications for Oxidative Stress and Inflammation in the Vascular System
Endocrine, Metabolic & Immune Disorders - Drug Targets Physiological Functions of Heat Shock Proteins
Current Protein & Peptide Science Potential Antibacterial Activity of Yemeni Sidr Honey Against <i>Pseudomonas aeruginosa</i> and <i>Streptococcus pyogenes</i>
Anti-Infective Agents Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
Current Pharmaceutical Design HM74a Agonists: Will they be the New Generation of Nicotinic Acid?
Current Topics in Medicinal Chemistry